Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086203
Status:
COMPLETED
Last Update Posted:
2015-03-25
First Post:
2004-06-28
Brief Title:
Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia CLL
Sponsor:
Point Therapeutics
Organization:
FDA Office of Orphan Products Development
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Chronic Lymphocytic Leukemia |
Keywords: